Rossello, Xavier
Piñero, Antonio
Fernández-Jiménez, Rodrigo
Sánchez-González, Javier
Pizarro, Gonzalo
Galán-Arriola, Carlos
Lobo-Gonzalez, Manuel
Vilchez, Jean Paul
García-Prieto, Jaime
García-Ruiz, Jose Manuel
García-Álvarez, Ana
Sanz-Rosa, David
Ibanez, Borja
Article History
Received: 16 May 2018
Accepted: 2 July 2018
First Online: 2 August 2018
Compliance with Ethical Standards
:
: Dr. Ibanez and Dr. García-Álvarez are inventors of the patent entitled “Use of selective beta-3 adrenergic agonists for the treatment of pulmonary hypertension” (PCT/ES2013/070611). Javier Sánchez-González is Philips employee.
: No human studies were carried out by the authors for this article.
: All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.